targtex.com
About company
TargTex is a drug development company focused on developing clinical candidates for different therapeutic indications. It provides therapeutics for Glioblastoma Multiforme. The company uses the artificial intelligence algorithm to find out the correlation between a small molecule and a target that is overexpressed in Glioblastoma Multiforme. The company is in the clinical trial of phase 2 study for its allosteric antagonist of a calcium channel that impairs GBM progression. These calcium channels are small molecules having anti-cancer properties. The company has also developed a biocompatible hydrogel formulation that was successfully tested in mice where GBM cells were injected intracranially. It was founded in 2019 and is based in Torres Vedras, Portugal.
